Takeda Pharmaceutical is a global pharmaceutical company that works to provide better medicines and effective vaccines for patients in more than 70 countries. As one of Shot@Life’s key partners, Takeda Pharmaceutical helps expand children’s access to lifesaving measles vaccines in approximately 40 countries in Africa, Asia, and Latin America. Takeda’s support will help vaccinate millions of children by 2026.
Takeda Pharmaceutical also supports health system strengthening efforts in 14 African countries. Since 2020, Takeda has partnered with Shot@Life to enhance disease surveillance systems, support vaccination efforts, and advocate for global immunization through a commitment of 550 million Japanese yen (more than $5 million USD).